Trials Currently Enrolling at Associated Neurologists

Alzheimer’s Disease | Epilepsy | Migraine | Multiple Sclerosis

Alzheimer’s Disease

Protocol Title"A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to assess the Efficacy, Safety, and Tolerability of AVP786 (deuterated [d6]- dextromethorphan hydrobromide [d6-DM]/ quinidine sulfate [Q]) for the treatment of agitation in patients with dementia of the Alzheimer's type"
Trial PhasePhase III
Principal Investigator (PI)Samuel Markind, MD
Protocol Number15-AVP-786-302
ClinicalTrials.gov Identifier:NCT02442778
For further information on this trial from ClinicalTrials.govClick here.
Protocol Title"A Randomized, Double-Blind, Placebo-Controlled and Delayed-Start Study of LY3314814 in Mild Alzheimer’s Disease Dementia (The Daybreak Study)"
Trial PhasePhase III
Principal Investigator (PI)Samuel Markind, MD
Protocol NumberI8D-MC-MZET
ClinicalTrials.gov Identifier:NCT02783573
For further information on this trial from ClinicalTrials.govClick here.
Protocol Title"A Double-Blind, Placebo-Controlled Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer’s Disease (Serene Study)"
Trial PhasePhase II
Principal Investigator (PI)Robert Bonwetsch, MD
Protocol NumberACP-103-032
ClinicalTrials.gov Identifier:NOT YET LISTED
For further information on this trial from ClinicalTrials.govTo be listed as soon as available.
Protocol Title"A phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group, efficacy and safety study of Crenezumab in patients with prodromal to mild Alzheimer's disease"
Trial PhasePhase III
Principal Investigator (PI)Samuel Markind, MD
Protocol NumberBN29952
ClinicalTrials.gov Identifier:NCT02353598
For further information on this trial from ClinicalTrials.govClick here.

Return to Top

Epilepsy

Protocol Title"A Double-Blind, Randomized, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Lacosamide as Adjunctive Therapy for Uncontrolled Primary Generalized Tonic-Clonic Seizures in Subjects with Idiopathic Generalized Epilepsy"
Trial PhasePhase III
Principal Investigator (PI)Williams Yorns, DO
Protocol NumberSP0982
ClinicalTrials.gov Identifier:NCT02408523
For further information on this trial from ClinicalTrials.govClick here.

Return to Top

Migraine

Protocol Title"A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled Single Attack Study to Evaluate the Efficacy, Safety, and Tolerability Of Oral Ubrogepant in the Acute Treatment Of Migraine"
Trial PhasePhase III
Principal Investigator (PI)Robert Bonwetsch, MD
Protocol NumberUBR-MD-01
ClinicalTrials.gov Identifier:NCT02828020
For further information on this trial from ClinicalTrials.govClick here.

Return to Top

Multiple Sclerosis

Protocol Title"A Multicenter, global, observational study to collect information on safety and to document the drug utilization of Tecfidera ™ (Dimethyl Fumarate) when used in routine medical practice in the treatment of MULTIPLE SCLEROSIS (ESTEEM)"
Trial PhasePhase IV
Principal Investigator (PI)David Greco, MD
Protocol Number109MS401
ClinicalTrials.gov Identifier:Click here.

Return to Top

If you would like to learn more about any of the trials above, please contact our Clinical Research Department at (203) 748-2551, extension 351 for further information.